Trials / Completed
CompletedNCT00410228
Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects
A Single Center, Randomized, Double-Blind, Placebo-and Positive-Controlled, Interleaved, Ascending Single Dose Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHTT956 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the safety and tolerability of ascending single oral doses of AHT956 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AHT956 |
Timeline
- Start date
- 2006-06-01
- First posted
- 2006-12-12
- Last updated
- 2007-06-22
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00410228. Inclusion in this directory is not an endorsement.